We are live on ! Find out more
PM

Prosight Management Portfolio holdings

AUM $580M
1-Year Est. Return 29.81%
This Fund
S&P 500
This Quarter Est. Return
-1.98%
1 Year Est. Return
+29.81%
3 Year Est. Return
+39.55%
5 Year Est. Return
-6.93%
10 Year Est. Return
–
AUM
$580M
AUM Growth
-$29.5M
Cap. Flow
-$5.55M
Cap. Flow %
-0.96%
Top 10 Hldgs %
70.73%
Holding
51
New
5
Increased
16
Reduced
15
Closed
15

Top Buys

Rank Stock Value
1
INSM icon
Insmed
INSM
+$45.5M
2
BSX icon
Boston Scientific
BSX
+$25.8M
3
IRTC icon
iRhythm Holdings
IRTC
+$18.1M
4
LKFT
Lakefront Biotherapeutics American Depositary Shares
LKFT
+$14M
5
MLYS icon
Mineralys Therapeutics
MLYS
+$12.3M

Top Sells

Rank Stock Value
1
PRCT icon
Procept Biorobotics
PRCT
+$42M
2
MGTX icon
MeiraGTx Holdings
MGTX
+$25.2M
3
WGS icon
GeneDx Holdings
WGS
+$24.9M
4
KURA icon
Kura Oncology
KURA
+$12.6M
5
CON
Concentra Group Holdings
CON
+$10.8M

Sector Composition

Rank Sector Weight
1 Healthcare 99.79%
2 Technology 0.21%
3 Industrials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PVLA
51
Palvella Therapeutics
PVLA
$2.16B
– –
-5,000
Closed -$623K
1 2
3

Similar funds

SC
Stempoint Capital New York $581M AUM 373.68% 1-Year Est. Return
CCWM
Correct Capital Wealth Management Clayton, Missouri $580M AUM 16.45% 1-Year Est. Return
CMA
Cedar Mountain Advisors Lake Oswego, Oregon $581M AUM 18.16% 1-Year Est. Return
RIS
Retirement Income Solutions Ann Arbor, Michigan $581M AUM 19.42% 1-Year Est. Return
MFS
McNamara Financial Services Marshfield, Massachusetts $580M AUM 17.89% 1-Year Est. Return
GFI
Global Frontier Investments Charleston, South Carolina $581M AUM 8.55% 1-Year Est. Return
PWM
Praetorian Wealth Management Carmel, California $580M AUM 19.43% 1-Year Est. Return
CA
COFG Advisors Oak Brook, Illinois $579M AUM

Prosight Management's Q2 2026 Portfolio in Review

As of Q2 2026, Prosight Management held 51 positions worth $580M, down 4.8% from $610M the previous quarter. Its ten largest holdings account for 71% of the portfolio.

Prosight Management's Q2 2026 filing shows 5 new, 16 increased, 15 reduced and 15 closed positions. Its largest new stake was Insmed: 375,609 shares worth $40M. The largest sale was Procept Biorobotics, an estimated $42M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, down from 100% a quarter earlier, followed by Technology and Industrials.

  • Prosight Management's largest Q2 2026 buy was Insmed: 375,609 shares worth $40M.
  • Prosight Management added most to Boston Scientific in Q2 2026, an estimated $25.8M increase.
  • Prosight Management's biggest Q2 2026 reduction was Procept Biorobotics, cutting an estimated $42M.
  • Prosight Management fully exited Concentra Group Holdings in Q2 2026, selling an estimated $10.8M.
  • Prosight Management's ten largest holdings make up 71% of its $580M portfolio in Q2 2026.
  • Prosight Management opened 5 new positions and closed 15 in Q2 2026.
  • Prosight Management's portfolio value fell 4.8% quarter-over-quarter to $580M.

Based on Prosight Management's 13F filing for Q2 2026, filed 14 Aug 2026.